click below
click below
Normal Size Small Size show me how
Mod1
Surgical Technologisht Pharm
Term | Definition |
---|---|
Absorption | of the drug from the site of administration into the blood circulation (it must dissolve in body fluids to be absorbed |
Adverse Effect | A harmful or abnormal result. An adverse effect may be caused by administration of a medication or by exposure to a chemical and be indicated by an untoward result such as by illness or death |
Agonist | Any drug/chemical molecule that binds a receptor and produces an effect -The magnitude of the drug effect is proportional to the amount of drug:receptor complexes formed |
Antagonist | Any drug/chemical molecule that blocks the effect of an agonist |
Bioavailability | fraction of the dose given which finds its way into systemic circulation; "F" |
Biotechnology | The newest source of drugs from the laboratory; results from a process known as genetic engineering or recombinant DNA technology |
Biotransformation | metabolism or breaking down of drug molecules in the liver |
Bolus | drug dose given rapidly IV. One time rapid infusion |
Contraindication | reason against giving a particular drug |
Distribution | process of transporting medication throughout the body |
Duration | time between onset and disapperance of drug effects |
Emulsion | a mixter of water and oil bound with an emulsifier |
Enteral | pertaining to the GI tract, a medication administration category |
Excretion | process of elimination of drug molecules from the body |
Hypersensitivity | adverse effect/allergic reaction resulting from a previous exposure to a drug |
Idiosyncratic effect | rare, unpredicatble adverse reaction to a drug |
Indication | reason or purpose for giving a med |
Local effect | limited to one place/part |
Onset | time between administration of a drug and the first appearance of drug effects |
Parenteral | any medication administration route other than the alimentary canal |
Pharmacodynamics | study of drugs and their actions in living organisms |
Pharmacokinetics | the study of metabolism and action of drugs: absorption, distribution, metabolism, excretion |
Plasma Protein Binding | the ability of drugs to attach to receptor sites on plasma proteins |
Reconstituted | process of mixing a semisolid substance with liquid in preparation for administration |
Side Effect | expected but unintended action/effect of a drug |
Solubility | ability of a medication form to be dissolved |
Suspension | undissolved chemical substances dispersed in liquid |
Synergist | med that enhances the effect of another drug |
Systemic Effect | response that affects the whole body |
Topical | pertaining to being applied to a surface |
Controlled Substances | medications that have potential for abuse |
Narcotics | a drug (such as opium or morphine) that in moderate doses dulls the senses, relieves pain, and induces profound sleep but in excessive doses causes stupor, coma, or convulsions |
DEA | Drug Enforcement Administration, an agency of the US Department of Justice; regulates interstate commerce in prescription drugs to prevent them from being used as drugs of abuse |
FDA | Food and Drug Administration: a federal agency responsible for monitoring trading and safety standards in the food and drug industries |
The Joint Commission | independent, not-for-profit group in the United States that administers voluntary accreditation programs for hospitals and other healthcare organizations. The commission develops performance standards that address crucial elements of operation, such as pa |
OTC | Over the Counter |
PDR | reference used by doctors and healthcare team members to look up prescription drug information. It is called The Physicians' Desk Reference. |
USP-NF | United States Pharmacopeia-National Formulary |